Ginkgo Bioworks Holdings Inc Class (DNA)
Deferred Revenue
$13.21M
Quarterly · Period ending: · USD
DNA Deferred Revenue
Latest reported$13.21Mperiod ending
Latest reported$13.21Mperiod ending
DNA Quarterly Deferred Revenue ($0.00 → $13.21M)
Quarterly deferred revenue
High-resolution chart · PNG
DNA deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 13,214,000 | |
| 14,910,000 | |
| 19,979,000 | |
| 25,236,000 | |
| 28,287,000 | |
| 33,653,000 | |
| 30,599,000 | |
| 22,894,000 | |
| 26,007,000 | |
| 33,612,000 | |
| 48,495,000 | |
| 42,762,000 | |
| 0 | |
| 47,518,000 | |
| 47,817,000 | |
| 40,505,000 | |
| 45,504,000 | |
| 35,232,000 | |
| 33,240,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |